Karen Smith
Overview
Karen Smith received an average of $3M in total compensation, including $450K in salary, at Jazz Pharmaceuticals from 2015 to 2017.
Source: SEC filings on June 15, 2018 and June 20, 2017.
Related executives
We found 21 more executives who work or worked at Jazz Pharmaceuticals.
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
Daniel Swisher
Jazz Pharmaceuticals
President
Renée Gal
Jazz Pharmaceuticals
Chief Financial Officer
Chris Tovey
Jazz Pharmaceuticals
Chief Operating Officer
Robert MSCE
Jazz Pharmaceuticals
Executive Vice President, Global Head of Research and Development
Kim Sablich
Jazz Pharmaceuticals
Executive Vice President and General Manager, North America
Robert Ianonne
Jazz Pharmaceuticals
Chief Medical Officer
Robert Iannone
Jazz Pharmaceuticals